Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.
Am J Physiol Renal Physiol. 2021 May 1;320(5):F870-F882. doi: 10.1152/ajprenal.00661.2020. Epub 2021 Mar 29.
Acute kidney injury (AKI) remains a significant clinical problem through its diverse etiologies, the challenges of robust measurements of injury and recovery, and its progression to chronic kidney disease (CKD). Bridging the gap in our knowledge of this disorder requires bringing together not only the technical resources for research but also the investigators currently endeavoring to expand our knowledge and those who might bring novel ideas and expertise to this important challenge. The University of Alabama at Birmingham-University of California-San Diego O'Brien Center for Acute Kidney Injury Research brings together technical expertise and programmatic and educational efforts to advance our knowledge in these diverse issues and the required infrastructure to develop areas of novel exploration. Since its inception in 2008, this O'Brien Center has grown its impact by providing state-of-the-art resources in clinical and preclinical modeling of AKI, a bioanalytical core that facilitates measurement of critical biomarkers, including serum creatinine via LC-MS/MS among others, and a biostatistical resource that assists from design to analysis. Through these core resources and with additional educational efforts, our center has grown its investigator base to include >200 members from 51 institutions. Importantly, this center has translated its pilot and catalyst funding program with a $37 return per dollar invested. Over 500 publications have resulted from the support provided with a relative citation ratio of 2.18 ± 0.12 (iCite). Through its efforts, this disease-centric O'Brien Center is providing the infrastructure and focus to help the development of the next generation of researchers in the basic and clinical science of AKI. This center creates the promise of the application at the bedside of the advances in AKI made by current and future investigators.
急性肾损伤(AKI)仍然是一个重大的临床问题,其病因多种多样,损伤和恢复的准确测量具有挑战性,并且会进展为慢性肾脏病(CKD)。要缩小我们对这种疾病的认识差距,不仅需要汇集研究的技术资源,还需要汇集目前努力拓展我们知识的研究人员、可能为这一重要挑战带来新想法和专业知识的人员。阿拉巴马大学伯明翰分校-加州大学圣地亚哥奥布莱恩急性肾损伤研究中心将技术专长、计划和教育工作结合起来,以推进我们在这些不同问题上的知识,并为新的探索领域提供必要的基础设施。自 2008 年成立以来,该奥布莱恩中心通过提供 AKI 的临床和临床前建模的最先进资源、促进关键生物标志物(包括 LC-MS/MS 检测的血清肌酐)测量的生物分析核心以及协助从设计到分析的生物统计学资源,扩大了其影响力。通过这些核心资源和额外的教育工作,我们中心的研究人员数量已从 51 个机构的 200 多名成员扩大。重要的是,该中心的试点和催化剂资助计划的投资回报率为 37 美元/美元。在提供的支持下,已经产生了超过 500 篇论文,相对引文比为 2.18±0.12(iCite)。通过其努力,该以疾病为中心的奥布莱恩中心正在为 AKI 的基础和临床科学的下一代研究人员提供基础设施和重点。该中心有望将当前和未来研究人员在 AKI 方面的进展应用于临床。